用于治疗二线以上复发或难治性经典型霍奇金淋巴瘤(r/r cHL)患者。
University of California San Diego, La Jolla, California, United States
Stanford Cancer Center, Palo Alto, California, United States
Smilow Cancer Center, New Haven, Connecticut, United States
UCLA Hematology/Oncology, Los Angeles, California, United States
Memorial Healthcare System, Hollywood, Florida, United States
Algemeen Ziekenhuis Klina, Brasschaat, Belgium
Washington University School of Medicine, Saint Louis, Missouri, United States
University of Wisconsin - Madison, Madison, Wisconsin, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Virginia Cancer Specialists, Fairfax, Virginia, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
NEXT oncology, San Antonio, Texas, United States
START Midwest, Grand Rapids, Michigan, United States
City of Hope-Duarte, Duarte, California, United States
City of Hope - Huntington Beach (Including Long Beach Elm), Huntington Beach, California, United States
City Of Hope, Irvine, California, United States
Azienda Ospedaliero Universitaria Careggi-S.O.D. Patologia Medica, Firenze, Italy
Azienda Ospedaliera Niguarda Ca' Granda, Milano, Italy
Instituto Europeo di Oncologia, Milano, Italy
University of California San Francisco, San Francisco, California, United States
Yale University, New Haven, Connecticut, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Florida Cancer Specialists East, West Palm Beach, Florida, United States
The Oncology Institute of Hope & Innovation, Cerritos, California, United States
The University of California, Los Angeles, Encino, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.